Advanced search
Publication Cover
Acta Orthopaedica Volume 83, 2012 - Issue 2
Journal homepage
1,245
Views
13
CrossRef citations to date
0
Altmetric
Guest editorials

Should deep venous thrombosis prophylaxis be used in fast-track hip and knee replacement?

Per Kjærsgaard-Andersen; Section for Hip and Knee Replacement, Department of Orthopaedics, Vejle Hospital, South Danish UniversityCorrespondence[email protected]
&
Henrik Kehlet; Section for Surgical Pathophysiology, Rigshospitalet
Pages 105-106 | Published online: 08 Mar 2012

  • Chandrasekaran S, Ariaretnam SK, Tsung J, Dickison D. Early mobilization after total knee replacement reduces the incidence of deep venous thrombosis. ANZ J Surg 2009; 79 (7-8): 526-9.
  • Davies RG, Rayment R. Primum non nocere - NICE guidelines on venous thromboembolism. Anaesthesia 2010; 65 (8): 774-8.
  • Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358 (26): 2765-75.
  • Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (6 Suppl) 2008; 133: 381S-453S.
  • Husted H, Otte KS, Kristensen BB, Orsnes T, Wong C, Kehlet H. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop 2010; 81 (5): 599-605.
  • Husted H, Lunn TH, Troelsen A, Gaarn-Larsen L, Kristensen BB, Kehlet H. Why still in hospital after fast-track hip and knee arthroplasty? Acta Orthop 2011; 82 (6): 679-84.
  • Jameson SS, Bottle A, Malviya A, Muller SD, Reed MR. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb. J Bone Joint Surg (Br) 2010; 92 (1): 123-9.
  • Kakkar AK, Rushton-Smith S. Venous thromboembolism pharmacologic prophylaxis after major surgery–-are we doing well or not well enough? Ann Surg 2011; 253 (2): 221-2.
  • Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372 (9632): 31-9.
  • Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop 2008; 79 (2): 174-83.
  • Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med 2010a; 363 (26): 2487-98.
  • Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet 2010b; 375 (9717): 807-15.
  • Lee Y-K, Chung CY, Koo K-H, Lee KM, Ji H-M, Park MS. Conflict of Interest in the Assessment of Thromboprophylaxis After Total Joint Arthroplasty: A Systematic Review. J Bone Joint Surg (Am) 2012; 94 (1): 27-33.
  • Malviya A, Martin K, Harper I, Muller SD, Emmerson KP, Partington PF, Reed MR. Enhanced recovery program for hip and knee replacement reduces death rate. Acta Orthop 2011; 82 (5): 577-81.
  • McDonald DA, Siegmeth R, Deakin AH, Kinninmonth AW, Scott NB. An enhanced recovery programme for primary total knee arthroplasty in the United Kingdom–follow up at one year. Knee 2011; doi: 10.1016/j.knee.2011.07.012
  • Polk HC, Jr., Qadan M. Prevention of venous thromboembolism after elective surgery is better influenced by judgement than by protocols. Br J Surg 2010; 97 (9): 1315-7.
  • Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, Ma Y, Roberts T, Sharrock N, Salvati E. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg (Br) 2012; 94 (1): 113-21.
  • Qadan M, Polk HC, Jr., Hohmann SF, Fry DE. A reassessment of needs and practice patterns in pharmacologic prophylaxis of venous thromboembolism following elective major surgery. Ann Surg 2011; 253 (2): 215-20.
  • Treasure T, Chong LY, Sharpin C, Wonderling D, Head K, Hill J. Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence: involvement of the orthopaedic surgical panel. J Bone Joint Surg (Br) 2010; 92 (5): 611-6.
  • Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373 (9676): 1673-80.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.